Get the Stockscreener App
129.42
3.86%
4.81
After Hours:
129.42
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $129.42, with a volume of 444.34K.
It is up +3.86% in the last 24 hours and up +12.34% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$124.61
Open:
$125.8
24h Volume:
444.34K
Relative Volume:
0.86
Market Cap:
$5.72B
Revenue:
$3.03B
Net Income/Loss:
$237.44M
P/E Ratio:
25.73
EPS:
5.03
Net Cash Flow:
$450.04M
1W Performance:
+7.24%
1M Performance:
+12.34%
6M Performance:
-26.32%
1Y Performance:
-45.87%
1-Day Range:
$125.80
$129.68
1-Week Range:
$119.86
$129.68
52-Week Range:
$108.90
$249.91
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
129.42 | 5.30B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex introduces Barrigel Rectal Spacer in Japan for prostate cancer radiotherapy - BioSpectrum Asia
Teleflex Incorporated Ranks High in Smart Money TrackerWeekly Stock Analysis & Safe Capital Growth Stock Tips - newsyoung.net
Teleflex and Vitality Road executives lead movement to improve women’s heart health in Greater Boston - www.heart.org
Intravenous Catheters Market Size to Hit USD 16.47 Billion by 2032, at 6.9% CAGR | Report by SNS Insider - GlobeNewswire Inc.
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Prov - TradeVenue
Teleflex announces the launch of Barrigel(TM) rectal spacer in Japan as a proven safe and effective option to minimize the harmful long-term side effects of prostate radiation therapy - MarketScreener
Teleflex's Strategic Expansion into Japan: A New Era for Oncology Innovation and Revenue Growth - AInvest
Teleflex launches Barrigel rectal spacer for prostate radiation in Japan - Investing.com
Teleflex Incorporated Launches Barrigel™ Rectal Spacer in Japan to Enhance Prostate Cancer Radiation Therapy Safety - Quiver Quantitative
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in - GlobeNewswire
85% Radiation Reduction: Teleflex's Revolutionary Barrigel Spacer Launches in Japan's Top Cancer Market - Stock Titan
Short Term Trend Reversal in Teleflex Incorporated PossibleJuly 2025 News Drivers & Community Verified Swing Trade Signals - beatles.ru
Teleflex Incorporated Recovery Linked to Earnings Surprise2025 Growth vs Value & Community Consensus Picks - newsimpact.co.kr
Teleflex closes deal with BIOTRONIK - MSN
Teleflex Incorporated Shows Early Signs of Technical StrengthJuly 2025 Technicals & AI Forecasted Entry and Exit Points - 선데이타임즈
How volatile is Teleflex Incorporated stockJuly 2025 Breakouts & High Win Rate Trade Tips - classian.co.kr
Teleflex Incorporated Flashes Rebound Signal in Oversold ConditionJuly 2025 Intraday Action & Risk Adjusted Swing Trade Ideas - kangso.co.kr
What institutional flow reveals about Teleflex IncorporatedQuarterly Performance Summary & Weekly Breakout Stock Alerts - Newser
Understanding Teleflex Incorporated’s price movement2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Will Teleflex Incorporated stock recover after recent dropWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
Statistical indicators supporting Teleflex Incorporated’s strengthPortfolio Performance Summary & Weekly Watchlist of Top Performers - Newser
Using data models to predict Teleflex Incorporated stock movementQuarterly Profit Report & Risk Controlled Swing Alerts - Newser
What high frequency data says about Teleflex IncorporatedQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - Newser
Teleflex Announces $0.34 Dividend: Market Impact and Recovery Insights on August 15 Ex-Dividend Date - AInvest
Teleflex Dividend Insights and Market Updates Ahead of Ex-Dividend Date on Aug 15, 2025 - AInvest
Is Teleflex Incorporated’s ROE strong enoughQuarterly Earnings Report & Smart Allocation Stock Tips - mustnews.co.kr
Teleflex Incorporated Sees Relief Buying After Extended Drop2025 Pullback Review & Accurate Intraday Trade Tips - sundaytimes.kr
Ex-Dividend Reminder: Eli Lilly, Teleflex and Royalty Pharma - Nasdaq
Teleflex’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
How Teleflex’s (TFX) BIOTRONIK Acquisition and Raised Guidance May Shape Its 2025 Growth Path - simplywall.st
KeyBanc Analyst Reiterates Buy on Integer Holdings with $145 Price Target - AInvest
Four Days Left Until Teleflex Incorporated (NYSE:TFX) Trades Ex-Dividend - 富途牛牛
Teleflex, Envista, Enovis, UnitedHealth Shares Surge Amid Positive Inflation Data - AInvest
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know - Yahoo Finance
Should Value Investors Buy Teleflex (TFX) Stock? - Yahoo Finance
Three Value Stocks with Questionable Fundamentals: Macy's, D.R. Horton, and Teleflex. - AInvest
Just Four Days Till Teleflex Incorporated (NYSE:TFX) Will Be Trading Ex-Dividend - simplywall.st
Is Now a Good Time to Reenter Teleflex IncorporatedEarly Entry Tips With Low Risk Zone Shared - beatles.ru
Live Scanner Shows Breakout on Teleflex IncorporatedTriple Digit Growth Focused Trade Plan Reviewed - metal.it
Pattern Scan Adds Teleflex Incorporated to WatchlistWeekly Growth Stock Entry Point Alerts Highlighted - beatles.ru
Teleflex Incorporated (NYSE:TFX) Q2 2025 Earnings Call Transcript - MSN
Teleflex Director Trades $115K in Company Stock Amid Positive Revenue Growth and Low Debt-to-Equity Ratio - AInvest
We Think You Can Look Beyond Teleflex's (NYSE:TFX) Lackluster Earnings - Yahoo Finance
Teleflex Executives and Directors Acquire Shares - TradingView
Teleflex Inc Directors Make Large Share Purchases. - AInvest
Teleflex Executives and Directors Increase Holdings - TradingView
Teleflex Raises 2025 Outlook Following Strong Q2 and BIOTRONIK Acquisition - MSN
Teleflex's AE05ML Device Study: A Potential Game-Changer in Laparoscopic Surgery. - AInvest
Reversal indicators forming on Teleflex Incorporated stockLoss Limitation Strategy Based on Analysis - Newser
Is Teleflex Incorporated in Accumulation Phase NowTrade Setups With AI Powered Filters Published - metal.it
Teleflex Incorporated Just Beat EPS By 46%: Here's What Analysts Think Will Happen Next - 富途牛牛
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Teleflex Incorporated Stock (TFX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Krakauer Andrew A | Director |
Aug 05 '25 |
Buy |
115.25 |
1,000 |
115,250 |
7,192 |
| Kelly Liam | Chairman, President & CEO |
Aug 05 '25 |
Buy |
115.07 |
1,500 |
172,605 |
45,267 |
| Ryu Jaewon | Director |
Aug 05 '25 |
Buy |
115.00 |
1,500 |
172,500 |
3,727 |
| HAGGERTY GRETCHEN R | Director |
Aug 06 '25 |
Buy |
114.75 |
500 |
57,375 |
6,305 |
| Duncan Candace H | Director |
May 05 '25 |
Option Exercise |
123.04 |
4,833 |
594,652 |
9,561 |
| Kelly Liam | Chairman, President & CEO |
Feb 19 '25 |
Option Exercise |
121.41 |
36,464 |
4,427,199 |
63,556 |
| Logue Daniel V. | CVP, General Counsel & Secty |
Feb 20 '25 |
Option Exercise |
121.00 |
1,620 |
196,020 |
14,328 |
| Klasko Stephen K. M.D. | Director |
Feb 20 '25 |
Option Exercise |
121.00 |
2,674 |
323,554 |
9,827 |
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):